Document is current
Any future updates will be listed below
-
Authors
Zenda, Sadamoto
Yamaguchi, Takuhiro
Yokota, Tomoya
Miyaji, Tempei
Mashiko, Tomoe
Tanaka, Mari
Yonemura, Masahito
Takeno, Misaki
Okano, Tomoka
Kawasaki, Toshikatsu
Nakamori, Yuko
Ishii, Shinobu
Shimada, Sanae
Kanamaru, Miyuki
Uchitomi, Yosuke
-
Funding
Funding for this research was provided by:
Japan Agency for The National Cancer Center Research and Development Fund (27-A-3)
Project Mirai Cancer Research Grants
- License Information
-
More Information
Article History
Received: 25 December 2017
Accepted: 20 August 2018
First Online: 6 September 2018
Ethics approval and consent to participate
: All patients will be required to provide written informed consent. The study is performed in accordance with the Declaration of Helsinki and the Japanese ethical guidelines for medical and health research involving human subjects. The protocol was approved by the IRB at each study site (Shizuoka Cancer Center, National Cancer Center Hospital East, Miyagi Cancer Center, Tohoku University, Nara Medical University, Kobe University, Cancer Institute Hospital, Hyogo Cancer Center, Aichi Cancer Center, Hokkaido University) as well as by the J-Support Protocol Review Committee. The protocol was the third edition as of January 2018.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
